跳至主要内容
临床试验/ACTRN12614000083695
ACTRN12614000083695已完成未知

A randomised controlled trial comparing a multi-faceted intervention based on a behavioural management clinical pathway for health professionals (MFI), against standard staff outreach education (SSE), in reducing anti-psychotic dosages for people with Huntington Disease (HD) in residential care facilities (RCF)

Huntington Disease Service, Westmead Hospital0 个研究点目标入组 38 人开始时间: 2014年1月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Male or Female 18 years or older
  • 2.Clinical HD, and a confirmatory family history OR >= 36 CAG repeats upon genetic testing
  • 3.Living in RCF in NSW- including group homes with 24-hour supervision, hostels and nursing homes
  • 4.Currently receiving a stable dose of regular antipsychotic medications for management of behavioural symptoms, for at least 4 months prior to enrolment (see exclusion criteria).
  • 5.Able to provide informed consent, or have a suitable senior person responsible who is able to provide informed consent.

排除标准

  • 1.Change of antipsychotic dose within 4 months prior to enrolment
  • 2.Psychotic symptoms (new hallucinations or delusions) within 1 year of enrolment
  • 3.People taking anti-psychotic medications solely for control of chorea
  • 4.Other unstable medical or psychiatric illness, making it unsafe to reduce anti-psychotic dose

研究者

发起方
Huntington Disease Service, Westmead Hospital

相似试验